⌘K

byHone Systems Hone

MENU

Market Intelligence

Timely disclosures Statutory filings News Filing Briefings Threads Shared themes

Komori×Hone Systems

Put AI to work in your business.Hone Systems builds AI into your day-to-day operations and keeps it running. Everything we build is yours.

Book 30 minutes →About Hone

What Komori does

Loading

HomeWatch Notifications

Discontinuation of ASP8062 development for opioid use disorder | Shared theme

⌘K

byHone Systems Hone

MENU

Market Intelligence

Timely disclosures Statutory filings News Filing Briefings Threads Shared themes

Komori×Hone Systems

Put AI to work in your business.Hone Systems builds AI into your day-to-day operations and keeps it running. Everything we build is yours.

Book 30 minutes →About Hone

What Komori does

ONE-WAYDated event · through FY2023

Discontinuation of ASP8062 development for opioid use disorder

An individual drug development item concerning the discontinuation of Phase II development of ASP8062 for opioid use disorder.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2023 →Last written FY2023

Directionhurts0 helps · 1 hurts · 0 flat

Loading

HomeWatch Notifications